Arrowhead Pharmaceuticals (ARWR) — Rating History

Complete AI committee score history · 16 sessions recorded · Updated nightly

← Overview 📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks

Date	Score	Rating	Recommendation	Conviction	Agreement	Analysts
2026-08-01	51.2	Hold	Watch	Contested	43%	7
2026-07-31	49.4	Hold	Watch	Contested	57%	7
2026-07-30	50.5	Hold	Watch	Contested	43%	7
2026-07-29	50.4	Hold	Watch	Contested	43%	7
2026-07-28	50.4	Hold	Watch	Contested	43%	7
2026-07-27	52.7	Hold	Watch	Contested	43%	7
2026-07-26	52.7	Hold	Watch	Contested	43%	7
2026-07-25	51.3	Hold	Watch	Contested	43%	7
2026-07-24	51.3	Hold	Watch	Contested	43%	7
2026-07-23	48.9	Hold	Watch	Contested	43%	7
2026-07-22	48.9	Hold	Watch	Contested	43%	7
2026-07-21	49.1	Hold	Watch	Contested	43%	7
2026-07-20	49.1	Hold	Watch	Contested	43%	7
2026-07-19	49.1	Hold	Watch	Contested	43%	7
2026-07-18	49.1	Hold	Watch	Contested	43%	7
2026-07-17	57.1	Buy	Watch	Contested	60%	5

About This Data

Committee scores are generated nightly by Innellis's 7-analyst AI committee. Each session analysts independently score Arrowhead Pharmaceuticals across fundamentals, momentum, and risk — then debate and reach a consensus. Scores range from 0 (most bearish) to 100 (most bullish). View track record →